Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine long-acting injectable microspheres in early primary Parkinson's disease
CTR20190042Phase 3Completed
- Sponsor
- Luye Pharma Group
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rotigotine in Parkinson's disease (PD), sponsored by Luye Pharma Group. Started Feb 2020; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on CTR20190042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190042.